PRTG and gastric cancer: In addition, the addition of sGC inhibitor NS-2028 and PKG inhibitor KT5823 significantly blocked the increase of cGMP levels (Fig. 5H, I) and pVASP levels (Fig. 5J, K) in gastric cancer cells induced by PRTG overexpression.